RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @CD_AACR: #OnlineFirst: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy. https://t.co/8zHeW…
RT @ElizSMcKenna: Now online in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy @fg…
RT @_joesia: Really amazing work and paper by @fg_herrera and team 👏 The creative refashioning of RT (low dose, metronomic, all sites) to…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @ElizSMcKenna: Now online in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy @fg…
RT @ElizSMcKenna: Now online in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy @fg…
RT @ElizSMcKenna: Now online in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy @fg…
amazing
RT @ElizSMcKenna: Now online in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy @fg…
#OnlineFirst: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy. https://t.co/8zHeWeeX9D. @fg_herrera @melitairving @GeorgeCoukos @OncoUNILCHUV @Ludwig_Cancer @CHUVLausanne @unil @FondationIsrec https://t.co/kVgm
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @weldeiry: Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy | Cancer Discovery https://t.co/5…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @weldeiry: Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy | Cancer Discovery https://t.co/5…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
Now online in @CD_AACR: Low-Dose #Radiotherapy Reverses Tumor Immune Desertification and Resistance to #Immunotherapy @fg_herrera @melitairving @GeorgeCoukos @OncoUNILCHUV @Ludwig_Cancer @CHUVLausanne @unil @FondationIsrec https://t.co/EJVU7ojkpN
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @PittetLab: 👍 Huge congratulations Fernanda and co-authors for producing this incredible story. For the readers: have a look at the the…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @jnt_khalifa: Amazing piece of work introducing « RACIM » as an original combination of low-dose RT⚡️(0.5-2Gy)+CPI+agonist CD40+low dose…
Amazing piece of work introducing « RACIM » as an original combination of low-dose RT⚡️(0.5-2Gy)+CPI+agonist CD40+low dose cyclophosph to reverse tumor immune desertification through mobilization of both innate and adaptive immunity. Successful translation
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
Fantastic piece of work shows what effects just 1Gy radiation can cause on the tumour microenvironment.
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @_joesia: Really amazing work and paper by @fg_herrera and team 👏 The creative refashioning of RT (low dose, metronomic, all sites) to…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @_joesia: Really amazing work and paper by @fg_herrera and team 👏 The creative refashioning of RT (low dose, metronomic, all sites) to…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @PittetLab: 👍 Huge congratulations Fernanda and co-authors for producing this incredible story. For the readers: have a look at the the…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
https://t.co/WL0tWx4ypH Fascinating! More of this! #radonc
RT @weldeiry: Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy | Cancer Discovery https://t.co/5…
RT @weldeiry: Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy | Cancer Discovery https://t.co/5…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
📢https://t.co/ieFeD7sCWB surfaces Twitter's most shared #oncology content in FREE realtime reports and weekly digests. Seen this? https://t.co/PhqphaHE0K (link first spotted in a tweet from @fg_herrera) #cancer #MedTwitter #MedTech
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy https://t.co/4J3sVSU0hT
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
@freddyeescorcia @CD_AACR Hi Freddy, It is out https://t.co/jcTquvNOZv
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @_joesia: Really amazing work and paper by @fg_herrera and team 👏 The creative refashioning of RT (low dose, metronomic, all sites) to…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
We have so much to learn about incorporating immunotherapies into cancer care.
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @weldeiry: Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy | Cancer Discovery https://t.co/5…
I wonder if neutrophil extracellular traps play a role despite the lower dose of radiation here. Certainly pre-treatment tumor immune context is an important factor. https://t.co/pRtKf6fZLF
RT @PittetLab: 👍 Huge congratulations Fernanda and co-authors for producing this incredible story. For the readers: have a look at the the…
RT @PittetLab: 👍 Huge congratulations Fernanda and co-authors for producing this incredible story. For the readers: have a look at the the…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @fg_herrera: Delighted to present our article in Cancer Discovery @CD_AACR, which uncovers a breakthrough in #cancerimmunotherapy #Oncol…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…
RT @ElementoLab: Great @CD_AACR paper by @CoukosGeorge and team shows further evidence in both mice and humans that low-dose (<2Gy) radioth…